高级检索
当前位置: 首页 > 详情页

A novel combined nomogram for predicting severe acute lower respiratory tract infection in children hospitalized for RSV infection during the post-COVID-19 period

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Pulmonary and Critical Care Medicine, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Medical Center for Pediatric Diseases, Kunming Children's Hospital, Kunming Medical University, Kunming, Yunnan, China. [2]Department of Pediatrics, The People's Hospital of Lincang, Lincang, Yunnan, China. [3]Department of Pediatrics, The People's Hospital of Baoshan, Baoshan, Yunnan, China. [4]Department of Pediatrics, The People's Hospital of Guandu District, The Fifth People's Hospital of Kunming, Kunming, Yunnan, China. [5]Department of Pediatrics, The People's Hospital of Lufeng, Lufeng, Yunnan, China. [6]Department of Pediatrics, The People's Hospital of Dali, The Third Affiliated Hospital of Dali University, Dali, Yunnan, China. [7]Department of Pediatrics, The First People's Hospital of Zhaotong, Zhaotong Hospital Affiliated to Kunming Medical University, Zhaotong, Yunnan, China. [8]Department of Pediatrics, The People's Hospital of Honghe, Honghe, Yunnan, China. [9]Department of Pediatrics, The People's Hospital of Wenshan Zhuang & Miao Autonomous Prefecture, Wenshan, Yunnan, China.
出处:

关键词: RSV severe acute lower respiratory tract infection children nomogram post-COVID-19 period machine learning

摘要:
Off-season upsurge of respiratory syncytial virus (RSV) infection with changed characteristics and heightened clinical severity during the post-COVID-19 era are raising serious concerns. This study aimed to develop and validate a nomogram for predicting the risk of severe acute lower respiratory tract infection (SALRTI) in children hospitalized for RSV infection during the post-COVID-19 era using machine learning techniques.A multicenter retrospective study was performed in nine tertiary hospitals in Yunnan, China, enrolling children hospitalized for RSV infection at seven of the nine participating hospitals during January-December 2023 into the development dataset. Thirty-nine variables covering demographic, clinical, and laboratory characteristics were collected. Primary screening and dimension reduction of data were performed using Least Absolute Shrinkage and Selection Operator (LASSO) regression, followed by identification of independent risk factors for RSV-associated SALRTI using Logistic regression, thus finally establishing a predictive nomogram model. Performance of the nomogram was internally evaluated by receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) based on the development dataset. External validation of our model was conducted using same methods based on two independent RSV cohorts comprising pediatric RSV inpatients from another two participating hospitals between January-March 2024.The development dataset included 1102 patients, 239 (21.7%) of whom developed SALRTI; while the external validation dataset included 249 patients (142 in Lincang subset and 107 in Dali subset), 58 (23.3%) of whom were diagnosed as SALRTI. Nine variables, including age, preterm birth, underlying condition, seizures, neutrophil-lymphocyte ratio (NLR), interleukin-6 (IL-6), lactate dehydrogenase (LDH), D-dimer, and co-infection, were eventually confirmed as the independent risk factors of RSV-associated SALRTI. A predictive nomogram was established via integrating these nine predictors. In both internal and external validations, ROC curves indicated that the nomogram had satisfactory discrimination ability, calibration curves demonstrated good agreement between the nomogram-predicted and observed probabilities of outcome, and DCA showed that the nomogram possessed favorable clinical application potential.A novel nomogram combining several common clinical and inflammatory indicators was successfully developed to predict RSV-associated SALRTI. Good performance and clinical effectiveness of this model were confirmed by internal and external validations.Copyright © 2024 Liu, Zhang, Liu, Li, Li, Wang, Li, Xiang, Lu, Yuan and Fu.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
第一作者:
第一作者机构: [1]Department of Pulmonary and Critical Care Medicine, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Medical Center for Pediatric Diseases, Kunming Children's Hospital, Kunming Medical University, Kunming, Yunnan, China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:87344 今日访问量:0 总访问量:719 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号